Ellevest Inc’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Ellevest Inc’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1	Closed	–	–	1813
2022 Q1	$0	Buy	+1	New	+$146	﹤0.01%	1718

Other funds holding AMPE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ellevest Inc's AMPE Position: Q2 2022 in Review

Ellevest Inc sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2022, closing a stake of 1 share.

Ellevest Inc first reported a position in AMPE in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.

Ellevest Inc reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
Ellevest Inc sold 1 Ampio Pharmaceuticals Inc. share in Q2 2022.
Ellevest Inc first reported a position in Ampio Pharmaceuticals Inc. in Q1 2022 and held it in 1 quarter.
Ellevest Inc's Ampio Pharmaceuticals Inc. position peaked at $0 in Q1 2022.
111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.

Based on Ellevest Inc's 13F filing for Q2 2022, filed 18 Jul 2022.